News

Building on these findings, Plattner and Markey oncologists are now collaborating with the pharmaceutical company Novartis to develop a Phase I clinical trial to test the safety and effectiveness of using nilotinib in relapsed melanoma patients.

Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

Recently published in PLOS One, the study used Kentucky Cancer Registry patient data from 2007-2011 to identify trends in epidermal growth factor receptor (EGFR) mutation testing and the usage of the EGFR inhibitor, erlotinib.

Markey has joined a consortium of 17 cancer centers across the country to better understand how COVID-19 has impacted cancer prevention, detection and care.

Artemisia annua or "Sweet Annie" has been used as a medicinal herb for centuries. With potential to treat a variety of cancers & even COVID-19, this plant is more relevant than ever & UK is showing how we can take it from Kentucky fields to the lab to our patients.

As a cancer prevention researcher trained in both basic laboratory science and epidemiology, Kuhs’ experience allows her to apply basic science findings to population-based studies, which will be essential to lowering cancer rates in the hardest-hit areas of the state.

Kentucky has one of the nation's highest incidences of oral cancer, according to the National Institutes of Health, and the prevalence of oral cancer in the targeted counties is as much as 54% higher than the state average.

A group led by the Markey Cancer Center researcher Qing-Bai She discovered that SMS is overexpressed in colorectal cancers and plays an important role in balancing cellular spermidine levels that are a necessary adaptation for colorectal cancer growth.

UK and ArtemiLife Inc. will collaborate on a clinical study using the extract of a medicinal plant grown in Kentucky to test for anti-cancer activity of Artemisia annua and to determine the recommended dose of Artemisia annua for future clinical trials.

It cannot be seen, smelled or tasted, and people are exposed by breathing radon in air when it comes in through gaps and cracks in their homes. It is the second-leading cause of lung cancer after tobacco smoking.